SCOLR Pharma, Inc. Partner Introduces Three New Products Based On SCOLR Technology

14 Nov 2006

·www.biospace.com

BELLEVUE, Wash.--(BUSINESS WIRE)--SCOLR Pharma, Inc. (AMEX: DDD) today announced the introduction of three once-daily CDT® based private label products -- Glucosamine/Chondroitin Sodium Free, Glucosamine, and Glucosamine/Chondroitin/MSM -- by its alliance partner, The Perrigo Company. The introduction took place at the Private Label Manufacturers Association 2006 PLMA Trade Show in Rosemont, Illinois, earlier this week.

Organizations

Perrigo Co. PlcSCOLR Pharma, Inc.

Indications

Targets

Drugs

Glucosamine Hydrochloride

Chat with Hiro

Hot reports

GPRC5D Target Patent Research Report

Patsnap Synapse

Global Drug R&D Express (July 2024)

PatSnap Synapse

siRNA Drug Amvuttra Patent Research and Practical Operation Guide

Patsnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.